Antiva Biosciences Funding & Investors
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV.
antivabio.comTotal Amount Raised: $140,346,016
Antiva Biosciences Funding Rounds
Series E
$53,000,000
Series E Investors
Canaan PartnersLumira Capital Investment ManagementSofinnovaHBM PartnersAdjuvant CapitalBioImpact CapitalGVSeries D
$31,000,000
Series D Investors
Mana VenturesLumira Capital Investment ManagementBrace PharmaDong-A ST Co.SofinnovaAdjuvant CapitalAlexandria Venture InvestmentsAvestriaGaingelsHBM Healthcare InvestmentsCanaan PartnersSirona CapitalOsage University PartnersGVSeries C
$15,000,000
Series C Investors
Canaan PartnersSirona CapitalOsage University PartnersBrace PharmaJLABSSofinnovaNS InvestmentHillhouse CapitalAlexandria Venture InvestmentsSeries C
$22,000,000
Series C Investors
Canaan PartnersBrace PharmaOsage University PartnersNS InvestmentSofinnovaAlexandria Venture InvestmentsSeries B
$16,000,000
Series B Investors
Canaan PartnersWende HuttonSofinnovaSeries Unknown
$1,745,019
Debt Financing
$1,100,000
Series Unknown
$501,006
Funding info provided by Diffbot.